TORONTO, July 7, 2022 /PRNewswire/ MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announces that
New FDA Clearance Illustrates the Utility of the i:X to Reliably DetectClinically Significant Bacteria that Impedes Wound Healing TORONTO, June 29, 2022 /PRNewswire/ MolecuLight Inc.
Authors of International Consensus Suggest that Fluorescence Imaging of Bacterial Burden is Positioned to Change Contemporary Paradigms of Post-Surgical Wound Management TORONTO and LONDON
KOVE Inc. to Distribute the MolecuLight Product Suite to Large South Korean Wound Care Market TORONTO and SEOUL, South Korea, April 6, 2022 /PRNewswire/ MolecuLight Inc., the leader
Wide-Spread Clinical Evidence using the MolecuLight i:X Platform Reveals its Significant Global Adoption and Proven Utility in Wound Care TORONTO and ABU DHABI, United Arab Emirates